NCT02555150View on ClinicalTrials.gov

A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

PRC-063

Oral extended-release capsule

DRUG

lisdexamfetamine dimesylate

Oral capsule

DRUG

Placebo

Oral placebo capsule

Trial Locations (1)

22908

University of Virginia, Charlottesville

All Listed Sponsors
collaborator

Purdue Pharma LP

INDUSTRY

lead

Rhodes Pharmaceuticals, L.P.

INDUSTRY

NCT02555150 - A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD | Biotech Hunter | Biotech Hunter